No Data
No Data
Terns Pharmaceuticals Management to Meet With Oppenheimer
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)
Express News | Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Insiders' US$5.17m Investments In Red Following Terns Pharmaceuticals' US$52m Dip In Market Value
TD Cowen Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy